Abbott's Meridia To Be Packaged With Patient Guide In 30-Count Bottle
This article was originally published in The Pink Sheet Daily
Executive Summary
The monthly supply bottles will replace existing 100-count bottles to simplify distribution of the new patient leaflet emphasizing the risk of increased blood pressure and heart rate. Meridia is the fourth of seven drugs flagged by FDA safety officer Graham to have safety information strengthened.
You may also be interested in...
Grassley Stumbles In Comments On Meridia’s Regulatory History
Finance Committee chair criticizes lack of action on the obesity agent, but Abbott revised the product’s risk management plan nearly a year ago.
Grassley Stumbles In Comments On Meridia’s Regulatory History
Finance Committee chair criticizes lack of action on the obesity agent, but Abbott revised the product’s risk management plan nearly a year ago.
Abbott’s Revised Meridia Labeling Adds Renal Precaution
Revised labeling for Abbott's Meridia (sibutramine) includes a precaution against using the weight-loss drug in patients with mild to moderate renal impairment or renal insufficiency